Clinical trials represent the crucial interface between innovative cancer research and successful therapy. They give patients direct access to the latest therapeutic developments and provide the possibility of promptly benefiting from current research findings. You can find information for patients about clinical trials in the "For Patients" section. Around 500 oncological clinical studies and Investigator Initiated Trials (IITs) are currently conducted at the National Center for Tumor Diseases (NCT) in Heidelberg.
Studies
Clinical studies by tumor disease or area can be found here:
Register for oncology studies
On the internet platform QuickQueck you will find all active studies of the NCT Heidelberg as well as other ongoing oncological studies recruiting in Germany. The platform enables physicians and patients to search quickly and specifically.
Study Requests and Feasibility Assessment
Sponsors, CROs, research networks, etc., please send your study request directly to the appropriate study team, according to the e-mail contact list below. You will receive prompt feedback, once the feasibility of your study request has been assessed. This flowchart shows our standard workflow for study/feasibility requests.
Study Team | Contact Person for Study/Feasibility Requests
|
CUP (Carcinoma of Unknown Primary) | PD Dr. Tilmann Bochtler |
Cross-Entity/Basket
|
|
Gastrointestinal Tumors
|
|
Gynecological Tumors/Breast Cancer | Prof. Dr. Andreas Schneeweiss |
Hematological Neoplasms | Studienportal Innere Medizin V |
Skin Tumors | Prof. Dr. Jessica Hassel |
Head and Neck Tumors | Dr. Sebastian Dieter |
Neuroendocrine Tumors | Dr. Leonidas Apostolidis |
Brain/CNS Tumors | Dr. Antje Wick |
Phase 1 Studies | Prof. Dr. Guy Ungerechts |
Prevention | Prof. Dr. Hermann Brenner |
Radiooncology | Prof. Dr. Dr. Jürgen Debus |
Sarcoma | Prof. Dr. Gerlinde Egerer |
Supportive Therapy | NCT Studienportal |
Thoracic Tumors | Prof. Dr. Michael Thomas |
Urogenital Tumors | Dr. Stefanie Zschäbitz |